Botanical Holdings is a dynamic investment holding company focusing on the legalised cannabis industry.
The company focuses on selective investments across all verticals of the legalised cannabis sector. Headed up by CEO Carl Esprey, Botanical Holdings has an experienced operations team consisting of professionals with expertise and experience across agriculture, agronomy, product development and pharmaceuticals.
Botanical Holdings CEO Carl Esprey says: “Our specialist team bring a unique blend of knowledge and experience to the legal medicinal cannabis industry. We have strengths. across investment and development, finance, research and law, which gives us a distinct competitive advantage.”
The active investment strategy for Botanical Holdings aims to deliver competitive returns to shareholders by applying its capital and resources within selected sectors of legal cannabis markets. Botanical Holdings also provides operational management to its risk-adjusted portfolio of companies within this dynamic market sector.
Botanical Holdings has a unique asset portfolio that includes products, capabilities and services, across legal cannabis sector.
“Our vision is to achieve a public listing by the end of 2020,” says Botanical Holdings CEO Carl Esprey. “We will then deliver consistent returns and capital growth for our shareholders through a range of strategic investments in the global legal cannabis industry.”
A major acquisition for Botanical Holdings is EuroCan, which is based in Portugal. EuroCan is at the forefront of the fast-growing medicinal cannabis industry and aims to become a world leader in the production of high-quality cannabis products and medicinal extracts.
EuroCan represents a significant step in Botanical Holdings’ move into Europe.